Wang, Z., Goto, Y., Allevato, M. M., Wu, V. H., Saddawi-Konefka, R., Gilardi, M., . . . Gutkind, J. S. (2021). Disruption of the HER3-PI3K-mTOR oncogenic signaling axis and PD-1 blockade as a multimodal precision immunotherapy in head and neck cancer. Nature Portfolio.
Chicago Style (17th ed.) CitationWang, Zhiyong, et al. Disruption of the HER3-PI3K-mTOR Oncogenic Signaling Axis and PD-1 Blockade as a Multimodal Precision Immunotherapy in Head and Neck Cancer. Nature Portfolio, 2021.
MLA (8th ed.) CitationWang, Zhiyong, et al. Disruption of the HER3-PI3K-mTOR Oncogenic Signaling Axis and PD-1 Blockade as a Multimodal Precision Immunotherapy in Head and Neck Cancer. Nature Portfolio, 2021.
Warning: These citations may not always be 100% accurate.